fbpx
vitiligo

Recruiting now

Victorian residents only

Vitiligo is a genetic disorder. In the absence of gene therapy, there is no cure. Nevertheless, most patients can achieve partial or complete repigmentation of individual lesions with topical treatment, phototherapy or surgery. Oral therapy is reserved for rapidly extending vitiligo.

For more info about Vitiligo, please visit our clinic page: Vitiligo

Eligibility

Gender: All
Age: 18-65
Criteria: Minimum 3 months clinical diagnosis of active non-segmental vitiligo

4%-50% of body involvement

Patients to have ≥ 1 active lesion

Trial Details
Duration: 60 weeks
Treatment: Oral JAK inhibitor/Placebo

Patients who complete the initial 24 weeks of the study will be eligible to enter open label extension phase

If you are interested and would like to participate in this trial, please click on the following link to answer a few short questions so one of our co-ordinators can get back to you: eligibility questionnaire

I’m interested & would like to participate in this trial

Accreditations & Memberships

Australasian Hair and Wool Research Society
victoria
international academy cosmetic dermatology
european medecines agency
gpce
deakin university
congress dermatology
bellberry limted
australiasian college dermatologists
australian government national health
australian government ip
australian clinical trials
asdr
albinism fellowship australia
aaaf
ahsf
american dermatological association
british association of dermatology
epworth
international society of dermatology
university of melbourne
Book An Appointment